Get startedLog in
    Picture of Elicera Therapeutics AB logo

    ELIC — Elicera Therapeutics AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Elicera Therapeutics Q3 Operating Loss Widens To SEK 7 Million

    Picture of Elicera Therapeutics AB logoElicera Therapeutics AB
    18/11/2022 07:20
    Nov 18 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS AB (PUBL) INTERIM REPORT 1 JANUARY -
30
SEPTEMBER 2022
    * Q3 OPERATING PROFIT/LOSS TOTALED SEK -7,028,100
(-6,753,799)
    * Q3 LOSS FOR PERIOD TOTALED SEK -7,118,476 (-6,753,799)

Source text for Eikon:  ID:nWkrbKMr7T 
Further company coverage:  ELIC.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Elicera Therapeutics AB

    See all news